Low-dose cyclosporine is safe in renal allografts with preexisting parenchymal damage
Lustig, S.; Yussim, A.; Shaharabani, E.; Nakache, R.; Shmueli, D.; Bar-Nathan, N.; Boner, G.; Shapira, Z.
Transplantation Proceedings 23(1 Pt 2): 1001-1002
1991
ISSN/ISBN: 0041-1345 PMID: 1989136 Document Number: 384533
Document emailed within 1 workday
Related Documents
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8Watanabe, K.; Yuge, K.; Sato, K.; Yamagishi, K.; Sonoda, K.; Masaki, Y.; Maruyama, S.; Takahara, H.; Matsubayashi, T.; Yago, K. 1989: Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion Transplantation Proceedings 21(1 Part 1): 1112-1115
Takeda, A.; Morozumi, K.; Uchida, K.; Yokoyama, I.; Takagi, H.; Yoshida, A.; Fujinami, T.; Thiel, G.; Gudat, F.; Mihatsch, M.J. 1993: Is cyclosporine-associated glomerulopathy a new glomerular lesion in renal allografts using CyA? Transplantation Proceedings 25(1 Part 1): 515-517
Kullendorff, C.M.; Evander, E. 1990: Distribution of renal parenchymal damage on 99m-Tc DMSA scintigraphy in vesico-ureteric reflux Annales Chirurgiae et Gynaecologiae 79(3): 153-156
Thiel, G.; Mihatsch, M.; Landmann, J.; Hermle, M.; Brunner, F.P.; Harder, F. 1985: Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Transplantation Proceedings 17(4 Suppl 1: 169-178
Nadeau, K.C.; Azuma, H.; Tilney, N.L. 1996: Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil Transplantation 62(9): 1363-1366
Lundgren, G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frödin, L.; Gäbel, H.; Lindholm, A.; Maurer, W.; Möller, E.; Persson, H. 1987: Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results Transplantation Proceedings 19(5): 3614-3618
Hossein-Nia, M.; Devlin, J.J.; Fagbohun, M.; Tredger, J.M.; Williams, R.; Johnston, A.; Holt, D.W. 1991: Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506 Transplantation Proceedings 23(6): 3150-3152
Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Rogerson, M.E.; Neild, G.H.; Rudge, C.J.; Wood, S.M.; Cairns, H.S.; Mansell, M.A.; Thompson, F.D. 1988: Renal transplants maintained on low-dose cyclosporine and prednisolone Transplantation Proceedings 20(3 Suppl 3): 114-116
Slapak, M.; Geoghegan, T.; Digard, N.; Ahmed, K.; Sharman, V.L.; Crockett, R. 1987: The use of low-dose cyclosporine a in combination with azathioprine and steroids in renal transplantation Transplantation Proceedings 19(2 Suppl 2: 41-45
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196
Kahan, B.D.; Julian, B.A.; Pescovitz, M.D.; Vanrenterghem, Y.; Neylan, J. 1999: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68(10): 1526-1532
Kootte, A.M.; Lensen, L.M.; van Bockel, J.H.; Paul, L.C. 1988: A randomized study comparing high- and low-dose regimens of cyclosporine in renal transplantation Transplantation Proceedings 20(3 Suppl 3: 136-139
Bennett, W.M.; Hosenpud, J.; Pantley, G.; Cobanoglu, A.; Starr, A.; Norman, D.J. 1989: Renal consequences of a low dose cyclosporine triple therapy regimen in cardiac transplantation Transplantation Proceedings 21(1 Part 3): 2479-2480
Mottram, P.L.; Mirisklavos, A.; Clunie, G.J. 1985: Cyclosporine and murine responses to alloantigens: effects of cyclosporine and donor-specific transfusions on delayed hypersensitivity reactions and murine skin allografts Transplantation Proceedings 17(2): 1646-1649
Nakaji, K.; Nakata, T.; Yasumura, T.; Ohmori, Y.; Oka, T.; Takada, K.; Muranishi, S. 1988: Prolongation of rat renal allograft survival by injection of a small dose of cyclosporine into the thoracic duct Transplantation Proceedings 20(2 Suppl 2: 298-300
Kokado, Y.; Ishibashi, M.; Jiang, H.; Takahara, S.; Sonoda, T. 1989: A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation Transplantation Proceedings 21(1 Pt 2): 1575-1578
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Miwa, H.; Van Loenen, M.; Vanderwerf, B.A. 1989: The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine Clinical Transplants 1989: 275-280